- Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Sara Panizo et al, 2021, International Journal of Molecular Sciences CrossRef - Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis
Minghui Wang et al, 2024, Frontiers in Pharmacology CrossRef - MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling
Liana Maries et al, 2021, Diagnostics CrossRef - miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy
Xiao-xu Yang et al, 2022, Canadian Journal of Physiology and Pharmacology CrossRef - Non-ischemic dilated cardiomyopathy and cardiac fibrosis
Bianca Olivia Cojan-Minzat et al, 2021, Heart Failure Reviews CrossRef - MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1
Yan Zhang et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef - Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics
Jinhong Chen et al, 2021, Frontiers in Genetics CrossRef - α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
Yosuke Kanno et al, 2022, Life CrossRef - MicroRNA Profiling of HL-1 Cardiac Cells-Derived Extracellular Vesicles
Serena Silvestro et al, 2021, Cells CrossRef